Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 20531301)

Published in Oncogene on June 07, 2010

Authors

R Dash1, Z-Z Su, S-G Lee, B Azab, H Boukerche, D Sarkar, P B Fisher

Author Affiliations

1: Department of Human and Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.

Articles by these authors

Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene (1995) 3.09

Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene (2007) 2.51

Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene (1994) 2.47

Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). Proc Natl Acad Sci U S A (1982) 2.36

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53. Oncogene (1999) 1.91

Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol Biol Cell (2001) 1.76

The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci U S A (1996) 1.73

Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther (2001) 1.71

The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci U S A (1998) 1.69

Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene (2001) 1.63

Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biol Ther (2008) 1.61

Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene (2009) 1.59

A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc Natl Acad Sci U S A (2001) 1.52

Effect of full-time, specialized physician supervision on the success of a large, urban emergency medical services system. Crit Care Med (1993) 1.43

The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene (1995) 1.40

Expression of adenovirus E1a and E1b gene products and the Escherichia coli XGPRT gene in KB cells. J Virol (1983) 1.39

Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med (2001) 1.37

Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene. Proc Natl Acad Sci U S A (1997) 1.36

Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes. J Supramol Struct (1979) 1.36

Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene (2006) 1.34

Cold-sensitive expression of transformation by a host range mutant of type 5 adenovirus. Proc Natl Acad Sci U S A (1983) 1.29

GADD45 proteins: central players in tumorigenesis. Curr Mol Med (2012) 1.26

Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. Gene (2001) 1.25

Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res (1985) 1.23

IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene (2011) 1.21

Effect of alternate nostril breathing exercise on cardiorespiratory functions. Nepal Med Coll J (2008) 1.21

Scientific, ethical, and logistical considerations in introducing a new operation: a retrospective cohort study from paediatric cardiac surgery. BMJ (2000) 1.19

Patterns of viral DNA integration in cells transformed by wild type or DNA-binding protein mutants of adenovirus type 5 and effect of chemical carcinogens on integration. J Virol (1980) 1.19

Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II. J Biol Chem (1984) 1.17

Interactions between adenovirus, a tumor promoter, and chemical carcinogens in transformation of rat embryo cell cultures. Proc Natl Acad Sci U S A (1978) 1.17

Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res (1999) 1.17

A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16

Effect on transformation of mutations in the early region 1b-encoded 21- and 55-kilodalton proteins of adenovirus 5. J Virol (1984) 1.15

Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells. Cancer Gene Ther (2010) 1.13

RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes. Proc Natl Acad Sci U S A (2000) 1.13

Characterization and comparison of membrane-associated and cytosolic cAMP-dependent protein kinases. Physicochemical and immunological studies on bovine cerebral cortex protein kinases. J Biol Chem (1979) 1.13

Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol (1998) 1.12

Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene (2001) 1.10

Phenotypic properties and tumor promotor-induced alterations in rat embryo cells transformed by adenovirus. Cancer Res (1979) 1.10

Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene (1998) 1.10

Deletion and insertion mutations in early region 1a of type 5 adenovirus that produce cold-sensitive or defective phenotypes for transformation. J Virol (1984) 1.10

Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. Adv Exp Med Biol (2000) 1.09

Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene (2010) 1.09

Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene (1998) 1.06

Isolated tubercular splenic abscess: can we defer splenectomy? Our single experience with anti-tuberculous therapy alone. Indian J Med Microbiol (2012) 1.06

In vitro antiherpetic activity of water-soluble amphotericin B methyl ester. Arch Virol (1975) 1.06

Molecular markers and determinants of prostate cancer metastasis. J Cell Physiol (2001) 1.05

PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells. Nucleic Acids Res (2001) 1.05

Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci U S A (1995) 1.05

Transformation of human skeletal muscle cells by simian virus 40. Proc Natl Acad Sci U S A (1983) 1.05

A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther (2008) 1.05

Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Mol Carcinog (1996) 1.04

Melittin shares certain cellular effects with phorbol ester tumour promoters. Nature (1979) 1.04

Effect of phorbol ester tumor promoters on the expression of melanogenesis in B-16 melanoma cells. Cancer Res (1979) 1.04

Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. Cancer Res (1984) 1.03

Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology (2001) 1.03

One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr (1985) 1.03

Identification of two subclasses of type II cAMP-dependent protein kinases. Neural-specific and non-neural protein kinases. J Biol Chem (1980) 1.02

Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc Natl Acad Sci U S A (1996) 1.02

Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo. Science (1987) 1.01

Complementary role of two fragments of domain V of 23 S ribosomal RNA in protein folding. J Biol Chem (1999) 1.01

Recent kala-azar cases in India: isozyme profiles of Leishmania parasites. Indian J Med Res (1995) 1.01

Monoclonal antibodies reactive with breast tumor-associated antigens. Adv Cancer Res (1985) 1.00

Regulation of mda-7 gene expression during human melanoma differentiation. Oncogene (2000) 0.99

Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem J (1998) 0.98

Reciprocal subtraction differential RNA display: an efficient and rapid procedure for isolating differentially expressed gene sequences. Proc Natl Acad Sci U S A (1998) 0.98

Tumor promoters induce membrane changes detected by fluorescence polarization. Biochem Biophys Res Commun (1979) 0.97

Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells. Oncogene (2000) 0.97

PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis. Proc Natl Acad Sci U S A (1999) 0.96

Protein folding in Escherichia coli: role of 23S ribosomal RNA. Biochim Biophys Acta (1999) 0.96

Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35). Cell Death Differ (2006) 0.96

Right gastroepiploic artery is the first alternative inflow source for hepatic arterial reconstruction in living donor liver transplantation. Transplant Proc (2012) 0.95

AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. J Cell Physiol (2000) 0.95

Effects of interferon on differentiation of normal and tumor cells. Pharmacol Ther (1985) 0.95

Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am J Clin Pathol (1989) 0.95

Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells. Exp Cell Res (1998) 0.95

Reversibility of progression of the transformed phenotype in Ad5-transformed rat embryo cells. Science (1985) 0.95

Polyene macrolide antibiotic cytotoxicity and membrane permeability alterations. I. Comparative effects of four classes of polyene macrolides on mammalian cells. J Cell Physiol (1978) 0.95

Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. J Immunol (1984) 0.95

Phytoavailability of biosolids phosphorus. J Environ Qual (2004) 0.95

Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells. Oncogene (2006) 0.94

Quantitative assay of erythrocyte "free" and zinc-protoporphyrin: clinical and genetic studies. Int J Biochem (1980) 0.94

Epidermal growth factor, like tumor promoters, enhances viral and radiation-induced cell transformation. Carcinogenesis (1981) 0.94

Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells. Anticancer Res (1996) 0.94

Activation of Ras/Raf protects cells from melanoma differentiation-associated gene-5-induced apoptosis. Cell Death Differ (2006) 0.94